| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide L Luznik, PV O'Donnell, HJ Symons, AR Chen, MS Leffell, M Zahurak, ... Biology of Blood and Marrow Transplantation 14 (6), 641-650, 2008 | 1889 | 2008 |
| Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation JR Wingard, SL Carter, TJ Walsh, J Kurtzberg, TN Small, LR Baden, ... Blood, The Journal of the American Society of Hematology 116 (24), 5111-5118, 2010 | 496 | 2010 |
| High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease L Luznik, J Bolaños-Meade, M Zahurak, AR Chen, BD Smith, R Brodsky, ... Blood, The Journal of the American Society of Hematology 115 (16), 3224-3230, 2010 | 457 | 2010 |
| HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease J Bolaños-Meade, EJ Fuchs, L Luznik, SM Lanzkron, CJ Gamper, ... Blood, The Journal of the American Society of Hematology 120 (22), 4285-4291, 2012 | 441 | 2012 |
| Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in … D Couriel, PA Carpenter, C Cutler, J Bolaños-Meade, NS Treister, ... Biology of Blood and Marrow Transplantation 12 (4), 375-396, 2006 | 382 | 2006 |
| Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide CG Kanakry, S Ganguly, M Zahurak, J Bolaños-Meade, C Thoburn, ... Science translational medicine 5 (211), 211ra157-211ra157, 2013 | 361 | 2013 |
| Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome YL Kasamon, L Luznik, MS Leffell, J Kowalski, HL Tsai, J Bolaños-Meade, ... Biology of Blood and Marrow Transplantation 16 (4), 482-489, 2010 | 313 | 2010 |
| Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide SR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ... Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 2015 | 301 | 2015 |
| Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors AS Kanate, A Mussetti, MA Kharfan-Dabaja, KW Ahn, A DiGilio, ... Blood, The Journal of the American Society of Hematology 127 (7), 938-947, 2016 | 288 | 2016 |
| A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study JE Levine, TM Braun, AC Harris, E Holler, A Taylor, H Miller, J Magenau, ... The Lancet Haematology 2 (1), e21-e29, 2015 | 287 | 2015 |
| A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality ML MacMillan, M Robin, AC Harris, TE DeFor, PJ Martin, A Alousi, VT Ho, ... Biology of Blood and Marrow Transplantation 21 (4), 761-767, 2015 | 274 | 2015 |
| Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults YL Kasamon, J Bolaños-Meade, GT Prince, HL Tsai, SR McCurdy, ... Journal of Clinical Oncology 33 (28), 3152, 2015 | 249 | 2015 |
| Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and Marrow Transplant … N Ghosh, R Karmali, V Rocha, KW Ahn, A DiGilio, PN Hari, V Bachanova, ... Journal of Clinical Oncology 34 (26), 3141, 2016 | 245 | 2016 |
| Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant … AM Alousi, DJ Weisdorf, BR Logan, J Bolanos-Meade, S Carter, ... Blood, The Journal of the American Society of Hematology 114 (3), 511-517, 2009 | 233 | 2009 |
| Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc … J Bolaños-Meade, R Reshef, R Fraser, M Fei, S Abhyankar, Z Al-Kadhimi, ... The Lancet Haematology 6 (3), e132-e143, 2019 | 228 | 2019 |
| Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study JE Levine, BR Logan, J Wu, AM Alousi, J Bolaños-Meade, JLM Ferrara, ... Blood, The Journal of the American Society of Hematology 119 (16), 3854-3860, 2012 | 212 | 2012 |
| Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS CG Kanakry, HL Tsai, J Bolaños-Meade, BD Smith, I Gojo, JA Kanakry, ... Blood, The Journal of the American Society of Hematology 124 (25), 3817-3827, 2014 | 198 | 2014 |
| Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide SR McCurdy, YL Kasamon, CG Kanakry, J Bolaños-Meade, HL Tsai, ... Haematologica 102 (2), 391, 2017 | 175 | 2017 |
| Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases RA Brodsky, L Luznik, J Bolanos-Meade, MS Leffell, RJ Jones, EJ Fuchs Bone marrow transplantation 42 (8), 523-527, 2008 | 163 | 2008 |
| The importance of IGHV mutational status in del (11q) and del (17p) chronic lymphocytic leukemia DE Gladstone, A Blackford, E Cho, L Swinnen, Y Kasamon, CD Gocke, ... Clinical Lymphoma Myeloma and Leukemia 12 (2), 132-137, 2012 | 156 | 2012 |
